Lead Product(s): Triferic
Therapeutic Area: Hematology
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Sun Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement January 14, 2020
Under the terms of the agreements, Sun Pharma will be the exclusive development and commercialization partner for Triferic in India and Rockwell Medical will supply the product to Sun Pharma.